Guangxi Medical University
Clinical trials sponsored by Guangxi Medical University, explained in plain language.
-
New strategy aims to stop liver Cancer's return after surgery
Disease control Recruiting nowThis study is testing whether adding a procedure called TACE after liver cancer surgery helps prevent the cancer from coming back. It will involve 442 people who have had surgery for liver cancer and are at high risk of recurrence. Participants will be randomly assigned to either…
Phase: PHASE3 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Massive review seeks best liver cancer treatment path
Knowledge-focused Recruiting nowThis study looks back at the medical records of 2000 people in China with advanced liver cancer who received combination treatments. The goal is to understand which treatment combinations work best and which patients benefit most from them. Researchers are analyzing past patient …
Sponsor: Guangxi Medical University • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC